Literature DB >> 7942937

Year-long weight loss treatment for obese patients with type II diabetes: does including an intermittent very-low-calorie diet improve outcome?

R R Wing1, E Blair, M Marcus, L H Epstein, J Harvey.   

Abstract

PURPOSE: To evaluate a year-long behavioral weight control program, used with and without an intermittent very-low-calorie diet (VLCD) in the treatment of type II diabetes mellitus. PATIENTS AND METHODS: Subjects (n = 93) were randomly assigned to 50-week treatment programs that used either a balanced low-calorie diet (LCD) of 1,000 to 1,000 kilocalories (kcal) per day throughout or included 2 12-week periods of a VLCD of 400 to 500 kcal per day alternating with the balanced LCD. Weight, glycemic control, blood pressure, and lipids were assessed at baseline, at the end of the year-long treatment, and at 2-year follow-up.
RESULTS: Subjects in the VLCD program lost significantly more weight than did LCD subjects at the end of the 50-week program (14.2 kg versus 10.5 kg; P = 0.057) and remained off diabetes medication longer (P < 0.05). These benefits of the VLCD were due primarily to the first 12 weeks of the diet; the second diet maintained, but did not increase, these effects. Subjects in both groups experienced marked improvements in glycemic control and cardiovascular risk factors over the year-long program, but attendance declined in the latter weeks of treatment and weight was regained. There was also marked recidivism in both groups in the year following treatment.
CONCLUSIONS: The intermittent VLCD improved weight loss and glycemic control, but these effects were quite modest and do not appear to justify the clinical use of an intermittent VLCD. Moreover, lengthening treatment to a full year did not prevent relapse. Thus, further research is needed to develop a successful approach to long-term weight control.

Entities:  

Mesh:

Year:  1994        PMID: 7942937     DOI: 10.1016/0002-9343(94)90302-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  43 in total

Review 1.  Effective management of obesity.

Authors:  S O'Meara; A M Glenny; C Wilson; A Melville; T A Sheldon
Journal:  Qual Health Care       Date:  1997-09

2.  Lifestyle modification in the management of obesity.

Authors:  Thomas A Wadden; Brian G McGuckin; Rebecca A Rothman; Stephanie L Sargent
Journal:  J Gastrointest Surg       Date:  2003 May-Jun       Impact factor: 3.452

3.  Effect of frequent phone contacts and Optional Food Provision on maintenance of weight loss.

Authors:  R R Wing; R W Jeffery; W L Hellerstedt; L R Burton
Journal:  Ann Behav Med       Date:  1996-09

Review 4.  Efficacy of commercial weight-loss programs: an updated systematic review.

Authors:  Kimberly A Gudzune; Ruchi S Doshi; Ambereen K Mehta; Zoobia W Chaudhry; David K Jacobs; Rachit M Vakil; Clare J Lee; Sara N Bleich; Jeanne M Clark
Journal:  Ann Intern Med       Date:  2015-04-07       Impact factor: 25.391

5.  Psychological wellbeing and biochemical modulation in response to weight loss in obese type 2 diabetes patients.

Authors:  Al-Jiffri Osama; Abd El-Kader Shehab
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

Review 6.  Protein sparing therapies in acute illness and obesity: a review of George Blackburn's contributions to nutrition science.

Authors:  Dylan D Thomas; Nawfal W Istfan; Bruce R Bistrian; Caroline M Apovian
Journal:  Metabolism       Date:  2017-12-07       Impact factor: 8.694

Review 7.  A systematic review of commercial weight loss programmes' effect on glycemic outcomes among overweight and obese adults with and without type 2 diabetes mellitus.

Authors:  Z W Chaudhry; R S Doshi; A K Mehta; D K Jacobs; R M Vakil; C J Lee; S N Bleich; R R Kalyani; J M Clark; K A Gudzune
Journal:  Obes Rev       Date:  2016-05-26       Impact factor: 9.213

Review 8.  Developmental gene x environment interactions affecting systems regulating energy homeostasis and obesity.

Authors:  Barry E Levin
Journal:  Front Neuroendocrinol       Date:  2010-03-03       Impact factor: 8.606

Review 9.  Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

Authors:  Bret H Goodpaster; David E Kelley
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

10.  Critical assessment of the current guidelines for the management and treatment of morbidly obese patients.

Authors:  B Burguera; A Agusti; P Arner; A Baltasar; F Barbe; A Barcelo; I Breton; T Cabanes; F F Casanueva; M E Couce; C Dieguez; M Fiol; J M Fernandez Real; X Formiguera; G Fruhbeck; M Garcia Romero; M Garcia Sanz; E Ghigo; R Gomis; K Higa; O Ibarra; A Lacy; A Larrad; L Masmiquel; V Moizé; B Moreno; J Moreiro; W Ricart; M Riesco; R Salinas; J Salvador; F X Pi-Sunyer; N Scopinaro; L Sjostrom; A Pagan; V Pereg; A Sánchez Pernaute; A Torres; J R Urgeles; A Vidal-Puig; J Vidal; M Vila
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.